ImetelChat

https://workforcenow.adp.com/mascsr/def ... bId=519269

Phase IV?

Heavy hitter patent attorney. Getting ready for a fight? Or ensuring protections for second gen oral agent.

Take a look at the third professor/advisor.

https://escholarship.org/content/qt8v24 ... 477acb.pdf

FWIW, no scientist would give credence to this small footnote since the numbers are so small but it is worth noting and filing away, the progression to AML in the Imetelstat group (1.7%) compared to placebo (3.3%). Perhaps larger studies and longer follow-ups might elucidate this.

RC, here you go:


https://www.postersessiononline.eu/1735 ... HO2024.pdf

Correct.

Thanks for the clarification. No further speculation on this one from me!

RC, good find, the SOHO meetings were just over a week ago. I could not find the original abstract on line but usually with any new presentations, Geron adds to their website so we should watch there. Dr. Santini first author. Maybe you can prod Geron's PR dept. The link you provided did refer to up...

Good point, doesn't look like a full time salaried position with all the usual accoutrements.

Thanks, RC, Looks like he may have been lured away. Be interesting to see what options he was granted in his new position.

Talk about riding off into the sunset, the sudden departure of Anil is looking more like an emergency corporate excision to deal with a commercially related problem (or possibly something personal), than it looks like placement in anticipation of some partnership, merger, or acquisition as raised as...

Great respect for the military academy. The guy is trained in leadership and has proven he knows how to use it. Good luck, Sir!

Jay seems to be solid tumor emphasis.

Jay, couldn’t find anything earlier today, let us know if you do.

Maybe not the first? See post July 12 re Onco360.

LWS, there is plenty of information on the MAIA website. Think of thio as another way to target the telomere.

No, not an oligo